Management of malignant hyperthermia: diagnosis and treatment

References

• BandschappOGirardTMalignant hyperthermiaSwiss Med Wkly2012142w1365222851008
   PubMed Web of Science ®Google Scholar
• BrewerGHeat-stroke as a post-operative complicationJ Am Med Assoc1900351685
   Google Scholar
• GibsonCTuttleJHeat stroke as a post-operative complicationMed News (NY)190077883884
   Google Scholar
• DenboroughMAForsterJFLovellRRMaplestonePAVilliersJDAnaesthetic deaths in a familyBr J Anaesth19623439539613885389
   PubMed Web of Science ®Google Scholar
• HarrisonGGControl of the malignant hyperpyrexic syndrome in MHS swine by dantrolene sodiumBr J Anaesth19754762651148076
   PubMed Web of Science ®Google Scholar
• BrittBAKalowWMalignant hyperthermia: a statistical reviewCan Anaesth Soc J1970172933154246871
   PubMedGoogle Scholar
• RosenbergHDavisMJamesDPollockNStowellKMalignant hyperthermiaOrphanet J Rare Dis200722117456235
   PubMed Web of Science ®Google Scholar
• KalowWBrittBATerreauMEHaistCMetabolic error of muscle metabolism after recovery from malignant hyperthermiaLancet197028958984097281
   PubMed Web of Science ®Google Scholar
• EllisFRHarrimanDGKeaneyNPKyei-MensahKTyrrellJHHalothane-induced muscle contracture as a cause of hyperpyrexiaBr J Anaesth1971437217225564247
   PubMed Web of Science ®Google Scholar
• [No authors listed]A protocol for the investigation of malignant hyperpyrexia (MH) susceptibility. The European Malignant Hyperpyrexia GroupBr J Anaesth198456126712696487446
   PubMed Web of Science ®Google Scholar
• LarachMGStandardization of the caffeine halothane muscle contracture test. North American Malignant Hyperthermia GroupAnesth Analg1989695115152675676
   PubMed Web of Science ®Google Scholar
• UrwylerADeufelTMcCarthyTWestSEuropean Malignant Hyperthermia GroupGuidelines for molecular genetic detection of susceptibility to malignant hyperthermiaBr J Anaesth20018628328711573677
   PubMed Web of Science ®Google Scholar
• LarachMGGronertGAAllenGCBrandomBWLehmanEBClinical presentation, treatment, and complications of malignant hyperthermia in North America from 1987 to 2006Anesth Analg201011049850720081135
   PubMed Web of Science ®Google Scholar
• ChamleyDPollockNAStowellKMBrownRLMalignant hyperthermia in infancy and identification of novel RYR1 mutationBr J Anaesth20008450050410823104
   PubMed Web of Science ®Google Scholar
• BradyJESunLSRosenbergHLiGPrevalence of malignant hyperthermia due to anesthesia in New York State, 2001–2005Anesth Analg20091091162116619762744
   PubMed Web of Science ®Google Scholar
• MonnierNKrivosic-HorberRPayenJFPresence of two different genetic traits in malignant hyperthermia families: implication for genetic analysis, diagnosis, and incidence of malignant hyperthermia susceptibilityAnesthesiology2002971067107412411788
   PubMed Web of Science ®Google Scholar
• HØrdingEpidemiology of malignant hyperthermiaSchulte Am EschJScholzJWapplerFMalignant HyperthermiaLengerich, GermanyPabst Science Publishers2000
   Google Scholar
• SchusterFJohannsenSSchneiderbangerDRoewerNEvaluation of suspected malignant hyperthermia events during anesthesiaBMC Anesthesiol2013132424053352
   PubMed Web of Science ®Google Scholar
• Bundesinstitut fuür Arzneimittel und MedizinprodukteBekanntmachung der Erloöschung fiktiver Arzneimittelzulassungen nach § 105 Abs. 3 Satz 1 des ArzneimittelgesetzesBundesanzeiger2001116162
   Google Scholar
• HopkinsPMMalignant hyperthermia: pharmacology of triggeringBr J Anaesth2011107485621624965
   PubMed Web of Science ®Google Scholar
• WedelDJGammelSAMildeJHIaizzoPADelayed onset of malignant hyperthermia induced by isoflurane and desflurane compared with halothane in susceptible swineAnesthesiology199378113811448512107
   PubMed Web of Science ®Google Scholar
• DGAIVerwendung von Succinylcholin – Aktualisierte Stellungnahme der DGAIAnästh Intensivmed200243831 German
   Google Scholar
• MelzerWHerrmann-FrankALuttgauHCThe role of Ca2+ ions in excitation-contraction coupling of skeletal muscle fibresBiochim Biophys Acta19951241591167742348
   PubMed Web of Science ®Google Scholar
• StrukALehmann-HornFMelzerWVoltage-dependent calcium release in human malignant hyperthermia muscle fibersBiophys J199875240224109788935
   PubMed Web of Science ®Google Scholar
• YangTAllenPDPessahINLopezJREnhanced excitation-coupled calcium entry in myotubes is associated with expression of RyR1 malignant hyperthermia mutationsJ Biol Chem2007282374713747817942409
   PubMed Web of Science ®Google Scholar
• MickelsonJRGallantEMLittererLAJohnsonKMRempelWELouisCFAbnormal sarcoplasmic reticulum ryanodine receptor in malignant hyperthermiaJ Biol Chem1988263931093153379071
   PubMed Web of Science ®Google Scholar
• MickelsonJRLouisCFMalignant hyperthermia: excitation-contraction coupling, Ca2+ release channel, and cell Ca2+ regulation defectsPhysiol Rev1996765375928618963
   PubMed Web of Science ®Google Scholar
• LitmanRSRosenbergHMalignant hyperthermia: update on susceptibility testingJAMA20052932918292415956637
   PubMed Web of Science ®Google Scholar
• StathopulosPBSeoMDEnomotoMAmadorFJIshiyamaNIkuraMThemes and variations in ER/SR calcium release channels: structure and functionPhysiology20122733134223223627
   PubMed Web of Science ®Google Scholar
• FillMCopelloJARyanodine receptor calcium release channelsPhysiol Rev20028289392212270947
   PubMed Web of Science ®Google Scholar
• HamiltonSLRyanodine receptorsCell Calcium20053825326016115682
   PubMed Web of Science ®Google Scholar
• McCarthyTVHealyJMHeffronJJLocalization of the malignant hyperthermia susceptibility locus to human chromosome 19q12-13.2Nature19903435625642300206
   PubMed Web of Science ®Google Scholar
• European Malignant Hyperthermia GroupCausative RyR1 mutations2013 Available from: http://www.emhg.org/genetics/mutations-in-ryr1/Accessed March 12, 2014
   Google Scholar
• RosenbergHMining for mutations in malignant hyperthermiaAnesth Analg201111397597622021794
   PubMed Web of Science ®Google Scholar
• BromanMHeineckeKIslanderGScreening of the ryanodine 1 gene for malignant hyperthermia causative mutations by high resolution melt curve analysisAnesth Analg20111131120112821965348
   PubMed Web of Science ®Google Scholar
• RobinsonRCarpenterDShawMAHalsallJHopkinsPMutations in RYR1 in malignant hyperthermia and central core diseaseHum Mutat20062797798916917943
   PubMed Web of Science ®Google Scholar
• SambuughinNHolleyHMuldoonSScreening of the entire ryanodine receptor type 1 coding region for sequence variants associated with malignant hyperthermia susceptibility in the north american populationAnesthesiology200510251552115731587
   PubMed Web of Science ®Google Scholar
• BrandomBWGenetics of malignant hyper ther miaScientificWorldJournal200661722173017195870
   PubMedGoogle Scholar
• MonnierNProcaccioVStieglitzPLunardiJMalignant-hyperthermia susceptibility is associated with a mutation of the alpha 1-subunit of the human dihydropyridine-sensitive L-type voltage-dependent calcium-channel receptor in skeletal muscleAm Hum Genet19976013161325
   PubMed Web of Science ®Google Scholar
• MarchantCLEllisFRHalsallPJHopkinsPMRobinsonRLMutation analysis of two patients with hypokalemic periodic paralysis and suspected malignant hyperthermiaMuscle Nerve20043011411715221887
   PubMed Web of Science ®Google Scholar
• KunstGGrafBMSchreinerRMartinEFinkRHDifferential effects of sevoflurane, isoflurane, and halothane on Ca2+ release from the sarcoplasmic reticulum of skeletal muscleAnesthesiology19999117918610422943
   PubMed Web of Science ®Google Scholar
• McGrathCJRempelWEJessenCRAddisPBCrimiAJMalignant hyperthermia-triggering liability of selected inhalant anesthetics in swineAm J Vet Res1981426046077332119
   PubMed Web of Science ®Google Scholar
• GronertGAMildeJHHyperbaric nitrous oxide and malignant hyperpyrexiaBr J Anaesth19815312387326174
   PubMed Web of Science ®Google Scholar
• FroebaGMarxTPazhurJXenon does not trigger malignant hyperthermia in susceptible swineAnesthesiology1999911047105210519508
   PubMed Web of Science ®Google Scholar
• BaurCPKlinglerWJurkat-RottKXenon does not induce contracture in human malignant hyperthermia muscleBr J Anaesth20008571271611094586
   PubMed Web of Science ®Google Scholar
• RiaziSLarachMGHuCWijeysunderaDMasseyCKraevaNMalignant hyperthermia in Canada: characteristics of index anesthetics in 129 malignant hyperthermia susceptible probandsAnesth Analg201411838138723842196
   PubMed Web of Science ®Google Scholar
• JohannsenSRoewerNSchusterFOndansetron-induced muscular contractures in malignant hyperthermia-susceptible individualsAnesth Analg201211592592822696611
   PubMed Web of Science ®Google Scholar
• CapacchioneJFMuldoonSMThe relationship between exertional heat illness, exertional rhabdomyolysis, and malignant hyperthermiaAnesth Analg20091091065106919617585
   PubMed Web of Science ®Google Scholar
• WapplerFAnesthesia for patients with a history of malignant hyperthermiaCurr Opin Anaesthesiol20102341742220173632
   PubMed Web of Science ®Google Scholar
• LoghmaneeFTobakMFatal malignant hyperthermia associated with recreational cocaine and ethanol abuseAm J Forensic Med Pathol198672462483788915
   PubMed Web of Science ®Google Scholar
• MerigianKSRobertsJRCocaine intoxication: hyperpyrexia, rhabdomyolysis and acute renal failureJ Toxicol Clin Toxicol1987251351483586084
   PubMed Web of Science ®Google Scholar
• WapplerFFiegeMSteinfathMEvidence for susceptibility to malignant hyperthermia in patients with exercise-induced rhabdomyolysisAnesthesiology2001949510011135728
   PubMed Web of Science ®Google Scholar
• WapplerFMalignant hyperthermiaEur J Anaesthesiol20011863265211553240
   PubMed Web of Science ®Google Scholar
• TautzTJUrwylerAAntogniniJFRiouBCase scenario: increased end-tidal carbon dioxide: a diagnostic dilemmaAnesthesiology201011244044620068452
   PubMed Web of Science ®Google Scholar
• LarachMGLocalioARAllenGCA clinical grading scale to predict malignant hyperthermia susceptibilityAnesthesiology1994807717798024130
   PubMed Web of Science ®Google Scholar
• AliSZTaguchiARosenbergHMalignant hyperthermiaBest Pract Res Clin Anaesthesiol20031751953314661655
   PubMedGoogle Scholar
• GlahnKPEllisFRHalsallPJRecognizing and managing a malignant hyperthermia crisis: guidelines from the European Malignant Hyperthermia GroupBr J Anaesth201010541742020837722
   PubMed Web of Science ®Google Scholar
• SchusterFMuller-ReibleCRMalignant hyperthermia – diagnostics, treatment and anaesthetic managementAnasthesiol Intensivmed Notfallmed Schmerzther200944758763 German19918708
   PubMedGoogle Scholar
• PodranskiTBouillonTSchumacherPMTaguchiASesslerDIKurzACompartmental pharmacokinetics of dantrolene in adults: do malignant hyperthermia association dosing guidelines work?Anesth Analg20051011695169916301243
   PubMed Web of Science ®Google Scholar
• SeiYBrandomBWBinaSPatients with malignant hyperthermia demonstrate an altered calcium control mechanism in B lymphocytesAnesthesiology2002971052105812411786
   PubMed Web of Science ®Google Scholar
• AllenGCLarachMGKunselmanARThe sensitivity and specificity of the caffeine-halothane contracture test: a report from the North American Malignant Hyperthermia Registry. The North American Malignant Hyperthermia Registry of MHAUSAnesthesiology1998885795889523799
   PubMed Web of Science ®Google Scholar
• GunterCQuantitative geneticsNature200845671919079046
   PubMed Web of Science ®Google Scholar
• SchusterFMetterleinTNegeleSAn in-vivo metabolic test for detecting malignant hyperthermia susceptibility in humans: a pilot studyAnesth Analg200810790991418713904
   PubMed Web of Science ®Google Scholar
• KimTWNemergutMEPreparation of modern anesthesia workstations for malignant hyperthermia-susceptible patients: a review of past and present practiceAnesthesiology201111420521221169802
   PubMed Web of Science ®Google Scholar
• PrinzhausenHCrawfordMWO’RourkeJPetrozGCPreparation of the Drager Primus anesthetic machine for malignant hyperthermia-susceptible patientsCan J Anaesth20065388589016960266
   PubMed Web of Science ®Google Scholar
• CrawfordMWPrinzhausenHPetrozGCAccelerating the washout of inhalational anesthetics from the Drager Primus anesthetic workstation: effect of exchangeable internal componentsAnesthesiology200710628929417264723
   PubMed Web of Science ®Google Scholar
• ShanahanHO’DonoghueRO’KellyPSynnottAO’RourkeJPreparation of the Drager Fabius CE and Drager Zeus anaesthetic machines for patients susceptible to malignant hyperthermiaEur J Anaesthesiol20122922923422388705
   PubMed Web of Science ®Google Scholar
• KimTWThamRQWashout times of desflurane, sevoflurane and isoflurane from the GE healthcare Aisys® and Avance® Carestation® and Aestiva® anesthesia systemPaediatr Anaesth2013231124113023947944
   PubMed Web of Science ®Google Scholar
• BirgenheierNStokerRWestenskowDOrrJActivated charcoal effectively removes inhaled anesthetics from modern anesthesia machinesAnesth Analg20111121363137021543783
   PubMed Web of Science ®Google Scholar
• MartinJWWelliverMDActivated charcoal adsorption of volatile anesthetic agents for anesthesia machine preparation of malignant hyperthermia susceptible patientsAANA J20138116917123923663
   PubMedGoogle Scholar